Literature DB >> 30670352

Effect of vaccination, comorbidities and age on mortality and severe disease associated with influenza during the season 2016-2017 in a Spanish tertiary hospital.

Enrique Gutiérrez-González1, José M Cantero-Escribano2, Lidia Redondo-Bravo2, Isabel San Juan-Sanz2, Ana Robustillo-Rodela2, Emilio Cendejas-Bueno3.   

Abstract

BACKGROUND: Identifying risk factors for complications or death associated with influenza remains crucial to target preventive interventions. Scores like the Charlson comorbidity index (CCI) may be of help. The aims of this study were to assess the effect of vaccination and comorbidities on severe influenza disease and influenza-related death among hospitalized patients during the season 2016/17; and to evaluate the validity of the CCI to predict death among these patients.
METHODS: Data from adult patients (≥18 years old) with influenza infection admitted to La Paz University Hospital (LPUH) were recorded during the 2016/17 epidemic. The effect of influenza vaccine to prevent severe influenza or death was evaluated using multivariate logistic regression models. The area under the curve of the CCI and the age-adjusted CCI were compared to assess the predictive effect on mortality.
RESULTS: A total of 342 adult patients with influenza infection were admitted, of which 83 developed severe influenza and 25 died during hospitalization. There were no differences between patients who survived and those who died concerning the CCI, but the age-adjusted CCI was higher in fatal cases (p-value=0.005). Influenza vaccine had no statistically significant effect on the risk of mortality (p-value=0.162) while age (OR: 1.12, p-value<0.001) and dementia (OR: 3.05, p-value=0.016) proved to be independent predictors for mortality. The seasonal vaccine was found to be protective for severe infection (OR: 0.54, p-value=0.019). The age-adjusted CCI was a better predictor of mortality than the crude CCI.
CONCLUSIONS: Age and dementia are significant independent risk factors for mortality associated with influenza among hospitalized patients. The age-adjusted CCI seems to be a better predictor of mortality than the crude CCI. Influenza vaccine has shown to be effective in preventing severe influenza in the season 2016/17 among hospitalized patients and should be promoted in population at risk.
Copyright © 2019 The Authors. Published by Elsevier Ltd.. All rights reserved.

Entities:  

Keywords:  Comorbidity; Influenza vaccine; Influenza virus; Mortality; Severe influenza

Mesh:

Substances:

Year:  2019        PMID: 30670352     DOI: 10.1016/j.jiph.2018.11.011

Source DB:  PubMed          Journal:  J Infect Public Health        ISSN: 1876-0341            Impact factor:   3.718


  15 in total

Review 1.  Role of Aging and the Immune Response to Respiratory Viral Infections: Potential Implications for COVID-19.

Authors:  Judy Chen; William J Kelley; Daniel R Goldstein
Journal:  J Immunol       Date:  2020-06-03       Impact factor: 5.422

2.  Results of a hospitalization policy of asymptomatic and pre-symptomatic COVID-19-positive long-term care facility residents in the province of Salzburg-a report from the AGMT COVID-19 Registry.

Authors:  Florian Huemer; Gabriel Rinnerthaler; Benedikt Jörg; Patrick Morre; Birgit Stegbuchner; Elisabeth Proksch; Stefanie Fleimisch; Hannes Oberkofler; Iris Kremser; Richard Greil; Alexander Egle
Journal:  Geroscience       Date:  2021-04-10       Impact factor: 7.713

3.  Comparison of clinical characteristics and disease outcome of COVID-19 and seasonal influenza.

Authors:  Stefan Kluge; Julian Schulze Zur Wiesch; Thomas Theo Brehm; Marc van der Meirschen; Annette Hennigs; Kevin Roedl; Dominik Jarczak; Dominic Wichmann; Daniel Frings; Axel Nierhaus; Tim Oqueka; Walter Fiedler; Maximilian Christopeit; Christian Kraef; Alexander Schultze; Marc Lütgehetmann; Marylyn M Addo; Stefan Schmiedel
Journal:  Sci Rep       Date:  2021-03-11       Impact factor: 4.379

4.  US Hospital Capacity Managers' Experiences and Concerns Regarding Preparedness for Seasonal Influenza and Influenza-like Illness.

Authors:  Gavin H Harris; Kimberly J Rak; Jeremy M Kahn; Derek C Angus; Olivia R Mancing; Julia Driessen; David J Wallace
Journal:  JAMA Netw Open       Date:  2021-03-01

5.  Patient Characteristics and Clinical Course of COVID-19 Patients Treated at a German Tertiary Center during the First and Second Waves in the Year 2020.

Authors:  Thomas Theo Brehm; Andreas Heyer; Kevin Roedl; Dominik Jarczak; Axel Nierhaus; Michael F Nentwich; Marc van der Meirschen; Alexander Schultze; Martin Christner; Walter Fiedler; Nicolaus Kröger; Tobias B Huber; Hans Klose; Martina Sterneck; Sabine Jordan; Benno Kreuels; Stefan Schmiedel; Marylyn M Addo; Samuel Huber; Ansgar W Lohse; Stefan Kluge; Julian Schulze Zur Wiesch
Journal:  J Clin Med       Date:  2021-05-24       Impact factor: 4.241

6.  Behavior of hospitalized severe influenza cases according to the outcome variable in Catalonia, Spain, during the 2017-2018 season.

Authors:  Núria Soldevila; Lesly Acosta; Ana Martínez; Pere Godoy; Núria Torner; Cristina Rius; Mireia Jané; Angela Domínguez
Journal:  Sci Rep       Date:  2021-06-30       Impact factor: 4.379

7.  A case series of coinfection with SARS-CoV-2 and influenza virus in Louisiana.

Authors:  Jennifer L Miatech; Nikhil N Tarte; Silpita Katragadda; Jeremy Polman; Sarah B Robichaux
Journal:  Respir Med Case Rep       Date:  2020-09-09

8.  Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis.

Authors:  Wei-Jie Guan; Wen-Hua Liang; Yi Zhao; Heng-Rui Liang; Zi-Sheng Chen; Yi-Min Li; Xiao-Qing Liu; Ru-Chong Chen; Chun-Li Tang; Tao Wang; Chun-Quan Ou; Li Li; Ping-Yan Chen; Ling Sang; Wei Wang; Jian-Fu Li; Cai-Chen Li; Li-Min Ou; Bo Cheng; Shan Xiong; Zheng-Yi Ni; Jie Xiang; Yu Hu; Lei Liu; Hong Shan; Chun-Liang Lei; Yi-Xiang Peng; Li Wei; Yong Liu; Ya-Hua Hu; Peng Peng; Jian-Ming Wang; Ji-Yang Liu; Zhong Chen; Gang Li; Zhi-Jian Zheng; Shao-Qin Qiu; Jie Luo; Chang-Jiang Ye; Shao-Yong Zhu; Lin-Ling Cheng; Feng Ye; Shi-Yue Li; Jin-Ping Zheng; Nuo-Fu Zhang; Nan-Shan Zhong; Jian-Xing He
Journal:  Eur Respir J       Date:  2020-05-14       Impact factor: 16.671

Review 9.  Smoking and COVID-19: Adding Fuel to the Flame.

Authors:  Vivek K Kashyap; Anupam Dhasmana; Andrew Massey; Sudhir Kotnala; Nadeem Zafar; Meena Jaggi; Murali M Yallapu; Subhash C Chauhan
Journal:  Int J Mol Sci       Date:  2020-09-09       Impact factor: 5.923

10.  Chronic kidney disease predicts poor outcomes of COVID-19 patients.

Authors:  Mahmut Gok; Hakki Cetinkaya; Tugba Kandemir; Erdem Karahan; İzzet Burak Tuncer; Cengiz Bukrek; Gulizar Sahin
Journal:  Int Urol Nephrol       Date:  2021-01-04       Impact factor: 2.370

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.